title: Re: effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer.
authors.affiliation: Department of Biochemistry, Boston University School of Medicine, Boston, MA, USA; Department of Urology, Boston University School of Medicine, Boston, MA, USA. Electronic address: atraish@bu.edu.
authors.forename: Abdulmaged M
authors.initials: AM
authors.lastname: Traish
authors.forename: Abraham
authors.initials: A
authors.lastname: Morgentaler
mesh_terms: D058891:5-alpha Reductase Inhibitors / Q000627:therapeutic use*; D000735:Androstenedione / Q000097:blood*; D018120:Finasteride / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000097:blood* / Q000188:drug therapy*; D013739:Testosterone / Q000097:blood*
chemical_list: D058891:5-alpha Reductase Inhibitors; D013739:Testosterone; D000735:Androstenedione; D018120:Finasteride
keywords: 5α-DHT; 5α-reductase; Diagnostic marker; Finasteride; Prostate cancer; Testosterone